ArticleAmerican journal of translational research2015

Matrine increases NKG2D ligand ULBP2 in K562 cells via inhibiting JAK/STAT3 pathway: a potential mechanism underlying the immunotherapy of matrine in leukemia.

Xuzhang Lu et al.PubMed ↗Full text ↗

No numbers read from the abstract.